Aethlon Medical (AEMD) Total Debt Growth (3y) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -0.07% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.11% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 1.72% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.34% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -14.39% |
| 10 | Aethlon Medical | 1.14 Mn | -5.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 24.24% |
| Dec 31, 2022 | 19.63% |
| Sep 30, 2022 | 20.50% |
| Jun 30, 2022 | 19.72% |
| Mar 31, 2022 | 23.02% |
| Dec 31, 2021 | 23.18% |
| Sep 30, 2021 | 10.72% |
| Jun 30, 2021 | 9.79% |
| Mar 31, 2021 | 19.89% |
| Dec 31, 2020 | 26.90% |
| Sep 30, 2020 | 47.78% |
| Jun 30, 2020 | 39.69% |
| Mar 31, 2020 | 24.51% |
| Dec 31, 2019 | 23.98% |
| Sep 30, 2019 | 20.24% |
| Jun 30, 2019 | 49.53% |
| Mar 31, 2019 | -16.77% |
| Dec 31, 2018 | -23.39% |
| Sep 30, 2018 | -21.47% |
| Jun 30, 2018 | -19.79% |
| Mar 31, 2018 | -14.80% |
| Dec 31, 2017 | -56.99% |
| Jun 30, 2017 | -61.04% |
| Mar 31, 2017 | -82.44% |
| Dec 31, 2016 | -57.94% |
| Sep 30, 2016 | -78.49% |
| Jun 30, 2016 | -67.18% |
| Mar 31, 2016 | -65.68% |
| Dec 31, 2015 | -40.44% |
| Sep 30, 2015 | -60.02% |
| Jun 30, 2015 | -60.65% |
| Mar 31, 2015 | -41.51% |
| Dec 31, 2014 | 9.48% |
| Jun 30, 2014 | -28.32% |
| Mar 31, 2014 | 74.70% |